Rapid Testing for COVID-19 in a pharmacy chain in a city in the Southwest of Bahia
DOI:
https://doi.org/10.33448/rsd-v10i17.24441Keywords:
COVID-19; Pharmacy; Diagnostic tests for COVID-19.Abstract
The virus that spreads the COVID-19 was discovered in cases of viral pneumonia in Wuhan (China), in 2019, and was named SARS-CoV-2, by the World Health Organization (WHO) on January 12, 2020. The virus belongs to a large family of viruses consisting of individual positive RNA connected with an envelope, it has an N (Nucleocapsid) protein, generally conserved among β-coronaviruses, constantly used as a diagnostic tool for COVID-19. The MedTest Coronavirus (COVID-19) Ag (Rapid Test) is intended to qualitatively detect the presence of the virus, and the MedTest Coronavirus (COVID-19) IgG/IgM (Rapid Test) has the purpose of detecting IgG antibodies and IgM for COVID-19. The present study aimed to describe the profile of the results obtained in the rapid testing for COVID-19 in a pharmacy chain with branches in a city in the Southwest of Bahia, Brazil. This was a field research, with the indirect participation of 241 people who took the tests, aged between 18 and 60 years. The results were collected and compared later with the symptoms reported by the patients through a questionnaire applied before each test. Thus, by performing the two tests, and comparing the results with the symptoms described by the patients, a relationship between the test result, symptom and patient age was obtained. Based on the results, it was found that patients who presented symptoms of fever and loss of taste were more associated with the positivity of the antigen test, and the symptom of sore throat had a lower correlation with the positivity for the same test. It was possible to verify the presence of positivity for COVID-19 in asymptomatic patients, and the importance of performing the antigen and antibody tests in due time.
References
Brasil, Ministério da Saúde. (2014). Informe Técnico - MERS-CoV (Novo Coronavírus). https://portalarquivos2.saude.gov.br/images/pdf/2014/junho/10/Infor me-Tecnico-para-Profissionais-da-Saude-sobre-MERS-CoV-09-06-2014.pdf.
Camargo, L. M. A., Silva, R. P. M. & Meneguetti, D. U. L. (2019). Tópicos de metodologia de pesquisa: Estudos de coorte ou cohorte prospectivo e retrospectivo. J. Hum. Growth Dev., 29(3), 433-436, http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-12822019000300016&lng=pt&nrm=iso.
CDC – Center for Disease control and Prevention (2021) Interim Guidance for Antigen Testing for SARS-CoV-2. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html#print
Cespedes, M. S. & Souza, J. C. R. P. (2020). SARS-CoV-2: uma revisão para o clínico. Scielo, 1-04, https://preprints.scielo.org/index.php/scielo/pre print/view/26/41
CFF - Conselho Federal de Farmácia. (2020). Pandemia fortalece conceito de "nova farmácia" pós-covid. 2020. https://www.cff.org.br/noticia.php?id=6083
CRFSP - Conselho Regional de Farmácia do Estado de São Paulo. (2020). Testes rápidos para COVID-19 em farmácias - CRF-SP. http://www.crfsp.org.br/noticias/11285-testes-r%C3%A1pidos.html
Costa, K. V. T. da et al. (2020). Olfactory and taste disorders in COVID-19: a systematic review. Brazilian Journal Of Otorhinolaryngology. 86(6), 790. http://dx.doi.org/10.1016/j.bjorl.2020.05.008.
Esperón, J. M. T. (2017). Pesquisa Quantitativa na Ciência da Enfermagem. Esc Anna Nery 2017;21(1):e20170027 https://www.scielo.br/j/ean/a/6c6QJ6BLDW3YRjFzfXwMMkC/?format=pdf&lang=pt
Grupo BR MED. (2021). Teste rápido COVID-19. https://www.grupobrmed.com.br/covid19
Jin, J.M et al. (2020). Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in public health, 8, 152. https://doi.org/10.3389/fpubh.2020.00152
Lana, R. M. et al. (2020). Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Cadernos de Saúde Pública, 36(3), 1-5, FapUNIFESP (SciELO). http://dx.doi.org/10.1590/0102-311x00019620.
Lima, F. E. T et al. (2020). Intervalo de tempo decorrido entre o início dos sintomas e a realização do exame para COVID-19 nas capitais brasileiras, agosto de 2020. Epidemiol. Serv. Saude, 30(1), 1-10, 4://dx.doi.org/10.1590/s1679-49742021000100021.
Lima-Costa, M. F & Barreto, S.M. (2003). Tipos de estudos epidemiológicos: conceitos básicos e aplicações na área do envelhecimento. Epidemiologia e Serviços de Saúde, 189-201, http://dx.doi.org/10.5123/s1679-49742003000400003.
Magno, L. et al. (2020). Desafios e propostas para ampliação da testagem e diagnóstico para COVID-19 no Brasil. Ciência & Saúde Coletiva, 25(9), 3356-3359,). http://dx.doi.org/10.1590/1413-81232020259.17812020.
Malmgren J., Guo, B. & Kaplan, H. G. (2020) Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State. PLoS ONE. 16(3): e0243042. https://doi.org/10.1371/journal.pone.0243042
Nunes, B. P. et al. (2020). Multimorbidade e população em risco para COVID-19 grave no Estudo Longitudinal da Saúde dos Idosos Brasileiros. Cadernos de Saúde Pública, 36(12), 2-2 https://scielosp.org/article/csp/2020.v36n12/e00129620/pt/.
Oliveira, L. M. S. et al. (2020). Estratégia de enfrentamento para covid-19 na atenção primária à saúde: relato de experiência em Salvador-BA. Revista Gaúcha de Enfermagem, 42, 2-2, http://dx.doi.org/10.1590/1983-1447.2021.20200138.
Sinha, N. & Balayla, G. (2020). Sequential battery of COVID-19 testing to maximize negative predictive value before surgeries. Revista do Colégio Brasileiro de Cirurgiões, 47, 5-5, https://www.scielo.br/j/rcbc/a/P3rkBwbK9M886sjbLB8tGzk/?lang=pt.
Uzunian, A. (2020). Coronavírus SARS-CoV-2 and Covid-19. Jornal Brasileiro de Patologia e Medicina Laboratorial, 56, 1-4, http://dx.doi.org/10.5935/1676-2444.20200053.
Vieira, L. M. F. et al. (2020). COVID-19 - Diagnóstico Laboratorial para Clínicos. Ciência & Saúde Coletiva, 1(1), 05-12. https://preprints.scielo.org/index.php/scielo/preprint/download/411/513/512.
Werneck, G. L. & Carvalho, M. S. (2020). A pandemia de COVID-19 no Brasil: crônica de uma crise sanitária anunciada. Cadernos de Saúde Pública, 36(5), 1-5 http://dx.doi.org/10.1590/0102-311x00068820.
Wise, J. (2020) Covid-19: Timing is critical for antibody tests, finds Cochrane review. BMJ 2020;369:m2584 http://dx.doi.org/10.1136/bmj.m2584
Wu, D., Wu, T., Liu, Q. & Yang, Z. (2020). The SARS-CoV-2 outbreak: what we know: what we know. International Journal Of Infectious Diseases, 94, 44-48, 12 http://dx.doi.org/10.1016/j.ijid.2020.03.004.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Leonardo Pereira Santos ; Antonio Carlos Ricardo Braga Junior; Aline Teixeira Amorim
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
